GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Diplomat Pharmacy Inc (NYSE:DPLO) » Definitions » Total Assets

Diplomat Pharmacy (Diplomat Pharmacy) Total Assets : $1,163 Mil (As of Sep. 2019)


View and export this data going back to 2014. Start your Free Trial

What is Diplomat Pharmacy Total Assets?

Diplomat Pharmacy's Total Assets for the quarter that ended in Sep. 2019 was $1,163 Mil.

Total Assets is connected with ROA %. Diplomat Pharmacy's annualized ROA % for the quarter that ended in Sep. 2019 was -57.24%. Total Assets is also linked to Revenue through Asset Turnover. Diplomat Pharmacy's Asset Turnover for the quarter that ended in Sep. 2019 was 1.05.


Diplomat Pharmacy Total Assets Historical Data

The historical data trend for Diplomat Pharmacy's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diplomat Pharmacy Total Assets Chart

Diplomat Pharmacy Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Total Assets
Get a 7-Day Free Trial 390.09 1,001.58 1,099.25 1,940.42 1,476.36

Diplomat Pharmacy Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,800.66 1,476.36 1,447.07 1,315.11 1,162.60

Diplomat Pharmacy Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Diplomat Pharmacy's Total Assets for the fiscal year that ended in Dec. 2018 is calculated as

Total Assets=Total Equity (A: Dec. 2018 )+Total Liabilities (A: Dec. 2018 )
=465.084+1011.275
=1,476

Diplomat Pharmacy's Total Assets for the quarter that ended in Sep. 2019 is calculated as

Total Assets=Total Equity (Q: Sep. 2019 )+Total Liabilities (Q: Sep. 2019 )
=131.032+1031.571
=1,163

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diplomat Pharmacy  (NYSE:DPLO) Total Assets Explanation

Total Assets is connected with ROA %.

Diplomat Pharmacy's annualized ROA % for the quarter that ended in Sep. 2019 is

ROA %=Net Income (Q: Sep. 2019 )/( (Total Assets (Q: Jun. 2019 )+Total Assets (Q: Sep. 2019 ))/ count )
=-709.12/( (1315.11+1162.603)/ 2 )
=-709.12/1238.8565
=-57.24 %

Note: The Net Income data used here is four times the quarterly (Sep. 2019) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Diplomat Pharmacy's Asset Turnover for the quarter that ended in Sep. 2019 is

Asset Turnover
=Revenue (Q: Sep. 2019 )/( (Total Assets (Q: Jun. 2019 )+Total Assets (Q: Sep. 2019 ))/ count )
=1301.197/( (1315.11+1162.603)/ 2 )
=1301.197/1238.8565
=1.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Diplomat Pharmacy Total Assets Related Terms

Thank you for viewing the detailed overview of Diplomat Pharmacy's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Diplomat Pharmacy (Diplomat Pharmacy) Business Description

Traded in Other Exchanges
N/A
Address
4100 South Saginaw Street, Flint, MI, USA, 48507
Diplomat Pharmacy Inc. is active in the U.S. healthcare sector. It provides specialty pharmacy and infusion services, including pharmacy solutions for chronic diseases. The company has two main segments: specialty pharmacy and pharmacy benefit management. Its specialty pharmacy segment offers solutions to dispense, deliver, and dose prescription drugs. The pharmacy benefit management segment offers services to help control pharmacy benefit dollars and maximize quality of care. It derives most of its revenue through prescription drug sales in the United States.
Executives
Brian T Griffin director, officer: Chairman and CEO
David C Dreyer director C/O SICOR INC, 19 HUGHES, IRVINE CA 92618-1902
Shawn Tomasello director C/O PHARMACYCLICS, INC, 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085
Regina M. Benjamin director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Benjamin Wolin director C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Jeffrey G Park director C/O DIPLOMAT PHARMACY, INC., 4100 S. SAGINAW ST., FLINT MI 48507
Sean Whelan director, officer: Chief Financial Officer C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Jeffrey M Rowe director, officer: EVP of Operations C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018

Diplomat Pharmacy (Diplomat Pharmacy) Headlines

From GuruFocus

Diplomat Announces Review of Strategic Alternatives

By PRNewswire PRNewswire 08-09-2019

Diplomat Using SMRxT Technology to Enhance Patient Care

By PRNewswire PRNewswire 04-26-2019